Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
Merck
Johnson and Johnson
Mallinckrodt

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Sucroferric oxyhydroxide - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for sucroferric oxyhydroxide and what is the scope of patent protection?

Sucroferric oxyhydroxide is the generic ingredient in one branded drug marketed by Vifor Fresenius and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sucroferric oxyhydroxide has eighty-five patent family members in thirty-eight countries.

There are four drug master file entries for sucroferric oxyhydroxide. One supplier is listed for this compound.

Recent Clinical Trials for sucroferric oxyhydroxide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 4
Vifor Fresenius Medical Care Renal PharmaPhase 2
Prim. Priv. Doz. Dr. Daniel CejkaPhase 2

See all sucroferric oxyhydroxide clinical trials

Recent Litigation for sucroferric oxyhydroxide

Identify potential future generic entrants

District Court Litigation
Case NameDate
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA2018-03-12

See all sucroferric oxyhydroxide litigation

Synonyms for sucroferric oxyhydroxide
12001-35-3
12678-06-7
1418308-48-1
63530-05-2
Colliron I.V.
DB09146
EINECS 232-464-7
Encifer
Fe-back
Fe-lib
Feojectin
Ferijet
Ferosoft S
Ferplex SS
FERRIC HYDROXIDE SUCROSE COMPLEX
Ferric oxide, saccharated
Ferric saccharate ...iron oxide (mix.)
Ferrivenin
Ferrum Hausmann i.v.
FZ7NYF5N8L
Iron oxide, saccharated
Iron sucrose [USAN:USP:BAN]
Iron sugar
Iviron
Neo-ferrum
Proferrin
Saccharated ferric oxide
Saccharated iron
Saccharated iron oxide
Succharated ferric oxide
Succharated ferric oxide [USAN:JAN]
Sucrofer
Sucrose, iron complex
UNII-FZ7NYF5N8L
Velphoro
XI 921
XI-921

US Patents and Regulatory Information for sucroferric oxyhydroxide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for sucroferric oxyhydroxide

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0868125 CA 2015 00007 Denmark   Start Trial PRODUCT NAME: BLANDING AF POLYNUKLEAERT JERN(III)-OXYHYDROXID, SUCROSE OG STIVELSE; REG. NO/DATE: EU/1/14/943/001-004 20140826
0868125 SPC/GB14/087 United Kingdom   Start Trial PRODUCT NAME: MIXTURE OF POLYNUCLEAR IRON(III)OXYHYDROXIDE, SUCROSE AND STARCHES; REGISTERED: UK EU/1/14/943/001 20140828; UK EU/1/14/943/002 20140828; UK EU/1/14/943/003 20140828; UK EU/1/14/943/004 20140828
0868125 PA2015003 Lithuania   Start Trial PRODUCT NAME: POLICIKLINES GELEZIES (III) OKSIHIDROKSIDO, SACHAROZES IR KRAKMOLU MISINYS; REGISTRATION NO/DATE: EU/1/14/943/001 - EU/1/14/943/004 20140826
0868125 425 Finland   Start Trial
0868125 C00868125/01 Switzerland   Start Trial PRODUCT NAME: FERRIOXYHYDROXIDUM/SACCHARUM/AMYLA; REGISTRATION NO/DATE: SWISSMEDIC 62986 22.01.2015
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Merck
Moodys
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.